search
Back to results

Reciprocating Medical Devices - a Study of a New Safety Device (RPD)

Primary Purpose

Osteoarthritis, Rheumatoid Arthritis, Trauma

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Reciprocating Procedure Device (RPD) - AVANCA Re No. 1091001
conventional syringe - BD Ref 309604
Sponsored by
University of New Mexico
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis focused on measuring arthrocentesis, injections, anesthesia, biopsy, aspiration, syringe, safety, pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • A syringe and needle procedure is required for the normal customary care of the patient

Exclusion Criteria:

  • hemorrhagic diathesis,
  • use of anticoagulants and antiplatelet agents child or susceptible population

Sites / Locations

  • University of New Mexico Health Sciences Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

1

2

Arm Description

The intervention is the use of the reciprocating procedure device (RPD) (AVANCA Re No. 1091001) (intervention) (Arm 1) with and without ultrasound guidance (intervention) in a syringe and needle procedure in comparison to a conventional syringe (BD Ref 309604) (control, Arm 2).

The conventional syringe (BD Ref 309604) is used to performed the syringe and needle procedure and outcome (effect of procedure (pain scores at 2 weeks and 6 months compared to preprocedural pain scores), and procedural pain (pain scores during procedure) are determined) and compared to Arm 1.

Outcomes

Primary Outcome Measures

Pain Using VAS (Visual Analogue Pain Scale)
0-10 cm VAS pain scale at 2 weeks compared to 0-10 cm VAS pain scale at 0 weeks where 0= no pain, and 10 = the worst pain imaginable. The difference (2 week VAS-0 week VAS) is the primary outcome measure.

Secondary Outcome Measures

Aspirated Fluid Volume
Aspirated fluid volume during procedure
Adverse Outcomes (Hemorrhage, Infection, Hematoma, Extravasation)
Physician Satisfaction
0- 10 cm visual analogue satisfaction scale (VASS) 0-10 cm VASS at 2 weeks compared to 0-10 cm VASS pain scale at 0 weeks where 0= completely dissatisfied, and 10 = completely satsified. The difference (2 week VAS-0 week VAS) is the outcome measure

Full Information

First Posted
March 21, 2008
Last Updated
February 2, 2016
Sponsor
University of New Mexico
search

1. Study Identification

Unique Protocol Identification Number
NCT00651625
Brief Title
Reciprocating Medical Devices - a Study of a New Safety Device
Acronym
RPD
Official Title
Randomized Controlled Trial of the Reciprocating Procedure Device Versus the Conventional Syringe in Syringe-and-Needle Procedures
Study Type
Interventional

2. Study Status

Record Verification Date
February 2016
Overall Recruitment Status
Completed
Study Start Date
November 2004 (undefined)
Primary Completion Date
January 2010 (Actual)
Study Completion Date
August 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of New Mexico

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study design is a randomized study to directly compare the performance and the outcome of syringe and needle procedures with a standard syringe or the new reciprocating procedure device (RDP), which is a type of safety syringe. Over a 5 year period, 820 subjects who require and assent to a syringe and needle procedure for their usual and customary care will be randomized to either a conventional syringe or the RPD with one arm with and without ultrasound guidance. The RPD is designed to be safer, faster, less painful, and more effective for the patient, and the mechanics of the RPD are intended to provide the physician with better needle control, resulting in less needle trauma to patient tissues, and thus, reduced bleeding and pain for the patient. This clinical trial will address whether the RPD is indeed superior to the conventional syringe for shots, injections, and needle procedures, and whether it is a safer, less painful syringe.
Detailed Description
* BACKGROUND The syringe is an ancient device designed principally to inject medications. However, because of the inherent biomechanics of the human hand and the interaction of the hand with the piston, the syringe is very stable and easily controlled the injection phase, but is extremely unstable and difficult to control in the aspiration phase. New reciprocating technology that accommodates the biomechanics of hand function has great promise of improving the stability and safety of hand-held devices, including procedure syringes. * EXPERIMENTAL DESIGN AND METHODS The study design is a randomized study to directly compare the performance and the outcome of syringe and needle procedures accomplished either with a standard syringe or the new reciprocating procedure device (RDP). Over a 5 year period, 820 subjects who require and assent to a syringe procedure for their usual and customary care will be randomized to either a conventional syringe or the reciprocating syringe. The following syringe procedures will be studied: 1) local anesthesia, 2) centesis (arthrocentesis, paracentesis, thoracentesis, amniocentesis, pericardiocentesis), 3) aspiration and puncture (aspiration of bursa, cyst, abscess, shunt, bone marrow, and other syringe aspiration procedures), 4) injection of a therapeutic or diagnostic substance into a joint, bursa, vessel, or other body structure, 5) fine needle biopsy with syringe vacuum of a mass or tissue, 6) irrigation procedures (wound, bladder, and other irrigation procedures), and 7) vascular access (introduction of a wire, catheter, or sheath into a blood vessel), and 8) with and without ultrasound guidance. In a subject with multiple individual procedure sites, or requires multiple separate biopsies, each will be randomized between the two syringes, and each biopsy or fluid sample will be analyzed separately (as is medically appropriate). The physicians who will perform the syringe procedures will be those physicians who usually perform the syringe procedures and are credentialed to do so. Outcome data collection will occur first by one of the investigators observing the procedure and collecting the data by real time interview and by chart review including cost analysis. Outcome data will include effectiveness (preprocedural pain, pain at 2 weeks post procedure, and pain at 6 months postprocedure), procedure time, patient pain, operator satisfaction, trauma to tissues, complications, diagnostic yield, overall medical care costs and hospital stay. Retrospective review of 30 charts of the device used clinically has also been approved (2006). Analysis of data will be performed by a statistician blinded to treatment group. *SIGNIFICANCE: The proposed study will be the first to study the clinical performance characteristics of a medical device that incorporates the new reciprocating technology designed to take advantage of the inherent biomechanical stability characteristics of the human hand. The preclinical studies presented in the preliminary data demonstrate markedly enhanced device performance characteristics, and much greater control and stability, strongly suggesting that reciprocating devices will be safer, more effective, more economical, and provide better patient outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Rheumatoid Arthritis, Trauma, Thyroid Nodule, Cancer
Keywords
arthrocentesis, injections, anesthesia, biopsy, aspiration, syringe, safety, pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
437 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
The intervention is the use of the reciprocating procedure device (RPD) (AVANCA Re No. 1091001) (intervention) (Arm 1) with and without ultrasound guidance (intervention) in a syringe and needle procedure in comparison to a conventional syringe (BD Ref 309604) (control, Arm 2).
Arm Title
2
Arm Type
Active Comparator
Arm Description
The conventional syringe (BD Ref 309604) is used to performed the syringe and needle procedure and outcome (effect of procedure (pain scores at 2 weeks and 6 months compared to preprocedural pain scores), and procedural pain (pain scores during procedure) are determined) and compared to Arm 1.
Intervention Type
Device
Intervention Name(s)
Reciprocating Procedure Device (RPD) - AVANCA Re No. 1091001
Other Intervention Name(s)
AVANCA RPD
Intervention Description
The RPD is a safety syringe device that is hypothesized to be safer, less painful, and more effective for patients undergoing a syringe and needle procedure (please see arm #1).
Intervention Type
Device
Intervention Name(s)
conventional syringe - BD Ref 309604
Other Intervention Name(s)
syringe, conventional syringe, traditional syringe
Intervention Description
the conventional syringe or the RPD will be used for syringe and needle procedures performed by physicians.
Primary Outcome Measure Information:
Title
Pain Using VAS (Visual Analogue Pain Scale)
Description
0-10 cm VAS pain scale at 2 weeks compared to 0-10 cm VAS pain scale at 0 weeks where 0= no pain, and 10 = the worst pain imaginable. The difference (2 week VAS-0 week VAS) is the primary outcome measure.
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Aspirated Fluid Volume
Description
Aspirated fluid volume during procedure
Time Frame
during procedure
Title
Adverse Outcomes (Hemorrhage, Infection, Hematoma, Extravasation)
Time Frame
during procedure, 2 weeks afterwards, and 6 months afterwards
Title
Physician Satisfaction
Description
0- 10 cm visual analogue satisfaction scale (VASS) 0-10 cm VASS at 2 weeks compared to 0-10 cm VASS pain scale at 0 weeks where 0= completely dissatisfied, and 10 = completely satsified. The difference (2 week VAS-0 week VAS) is the outcome measure
Time Frame
during procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: A syringe and needle procedure is required for the normal customary care of the patient Exclusion Criteria: hemorrhagic diathesis, use of anticoagulants and antiplatelet agents child or susceptible population
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wilmer L Sibbitt, Jr., MD
Organizational Affiliation
University of New Mexico
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of New Mexico Health Sciences Center
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87131
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
18796180
Citation
Sibbitt RR, Palmer DJ, Sibbitt WL Jr. Reciprocating procedure device for thyroid cyst aspiration and ablative sclerotherapy. J Laryngol Otol. 2009 Mar;123(3):343-5. doi: 10.1017/S0022215108003551. Epub 2008 Sep 17.
Results Reference
background
PubMed Identifier
18656735
Citation
Sibbitt RR, Sibbitt WL Jr, Palmer DJ, Bankhurst AD. Needle aspiration of peritonsillar abscess with the new safety technology: the reciprocating procedure device. Otolaryngol Head Neck Surg. 2008 Aug;139(2):307-9. doi: 10.1016/j.otohns.2008.04.003. No abstract available.
Results Reference
background
PubMed Identifier
18583303
Citation
Sibbitt RR, Palmer DJ, Sibbitt WL Jr. Integration of patient safety technologies into sclerotherapy for varicose veins. Vasc Endovascular Surg. 2008 Oct-Nov;42(5):446-55. doi: 10.1177/1538574408318479. Epub 2008 Jun 25.
Results Reference
background
PubMed Identifier
18576358
Citation
Moorjani GR, Bedrick EJ, Michael AA, Peisajovich A, Sibbitt WL Jr, Bankhurst AD. Integration of safety technologies into rheumatology and orthopedics practices: a randomized, controlled trial. Arthritis Rheum. 2008 Jul;58(7):1907-14. doi: 10.1002/art.23499.
Results Reference
background
PubMed Identifier
18568356
Citation
Sibbitt RR, Palmer DJ, Bankhurst AD, Sibbitt WL Jr. Integration of new safety technologies for needle aspiration of breast cysts. Arch Gynecol Obstet. 2009 Mar;279(3):285-92. doi: 10.1007/s00404-008-0710-8. Epub 2008 Jun 21.
Results Reference
background
PubMed Identifier
18412301
Citation
Moorjani GR, Michael AA, Peisajovich A, Park KS, Sibbitt WL Jr, Bankhurst AD. Patient pain and tissue trauma during syringe procedures: a randomized controlled trial. J Rheumatol. 2008 Jun;35(6):1124-9. Epub 2008 Apr 15.
Results Reference
background
PubMed Identifier
17057008
Citation
Sibbitt RR, Sibbitt WL Jr, Nunez SE, Kettwich LG, Kettwich SC, Bankhurst AD. Control and performance characteristics of eight different suction biopsy devices. J Vasc Interv Radiol. 2006 Oct;17(10):1657-69. doi: 10.1097/01.RVI.0000236837.47302.8E.
Results Reference
background
Citation
Gerstein NS, Martin HB, Toma, G MD; Sibbitt RR, Sibbitt WL Jr.. Central venous access with the new safety technology the reciprocating procedure device. Journal Clinical Anesthesiology 2008 (In Press).
Results Reference
background
PubMed Identifier
17143968
Citation
Bankhurst AD, Nunez SE, Draeger HT, Kettwich SC, Kettwich LG, Sibbitt WL Jr. A randomized controlled trial of the reciprocating procedure device for intraarticular injection of corticosteroid. J Rheumatol. 2007 Jan;34(1):187-92.
Results Reference
result
PubMed Identifier
17278943
Citation
Nunez SE, Draeger HT, Rivero DP, Kettwich LG, Sibbitt WL Jr, Bankhurst AD. Reduced pain of intraarticular hyaluronate injection with the reciprocating procedure device. J Clin Rheumatol. 2007 Feb;13(1):16-9. doi: 10.1097/01.rhu.0000256280.85507.bd.
Results Reference
result
PubMed Identifier
18281176
Citation
Nunez SE, Bedrick EJ, Kettwich SC, Kettwich LG, Bankhurst AD, Sibbitt WL Jr. A randomized, controlled trial of the reciprocating procedure device for local anesthesia. J Emerg Med. 2008 Aug;35(2):119-25. doi: 10.1016/j.jemermed.2007.08.060. Epub 2008 Feb 20.
Results Reference
result
PubMed Identifier
16339287
Citation
Draeger HT, Twining JM, Johnson CR, Kettwich SC, Kettwich LG, Bankhurst AD. A randomised controlled trial of the reciprocating syringe in arthrocentesis. Ann Rheum Dis. 2006 Aug;65(8):1084-7. doi: 10.1136/ard.2005.045781. Epub 2005 Dec 8.
Results Reference
result
PubMed Identifier
17885154
Citation
Sander O. Intra-articular corticosteroid injections with the reciprocating procedure device reduced procedural pain and duration more than the conventional syringe. Evid Based Med. 2007 Aug;12(4):106. doi: 10.1136/ebm.12.4.106. No abstract available.
Results Reference
result
PubMed Identifier
16511940
Citation
Sibbitt W Jr, Sibbitt RR, Michael AA, Fu DI, Draeger HT, Twining JM, Bankhurst AD. Physician control of needle and syringe during aspiration-injection procedures with the new reciprocating syringe. J Rheumatol. 2006 Apr;33(4):771-8. Epub 2006 Mar 1.
Results Reference
result
PubMed Identifier
19037606
Citation
Park KS, Peisajovich A, Michael AA, Sibbitt WL Jr, Bankhurst AD. Should local anesthesia be used for arthrocentesis and joint injections? Rheumatol Int. 2009 Apr;29(6):721-3. doi: 10.1007/s00296-008-0785-3. Epub 2008 Nov 27. No abstract available.
Results Reference
result
PubMed Identifier
19265345
Citation
Michael AA, Moorjani GR, Peisajovich A, Park KS, Sibbitt WL Jr, Bankhurst AD. Syringe size: does it matter in physician-performed procedures? J Clin Rheumatol. 2009 Mar;15(2):56-60. doi: 10.1097/RHU.0b013e31819c1fc4.
Results Reference
result
PubMed Identifier
22452536
Citation
Kettwich LG, Sibbitt WL Jr, Emil NS, Ashraf U, Sanchez-Goettler L, Thariani Y, Bankhurst AD. New device technologies for subcutaneous fat biopsy. Amyloid. 2012 Jun;19(2):66-73. doi: 10.3109/13506129.2012.666508. Epub 2012 Mar 27.
Results Reference
derived
PubMed Identifier
21617556
Citation
Sibbitt WL Jr, Michael AA, Poole JL, Chavez-Chiang NR, Delea SL, Bankhurst AD. Nerve blocks at the wrist for painful injections of the palm. J Clin Rheumatol. 2011 Jun;17(4):173-8. doi: 10.1097/RHU.0b013e31821bfed0.
Results Reference
derived
PubMed Identifier
21469942
Citation
Hayward WA, Haseler LJ, Kettwich LG, Michael AA, Sibbitt Wl Jr, Bankhurst AD. Pressure generated by syringes: implications for hydrodissection and injection of dense connective tissue lesions. Scand J Rheumatol. 2011;40(5):379-82. doi: 10.3109/03009742.2011.560892. Epub 2011 Apr 6.
Results Reference
derived
PubMed Identifier
21447197
Citation
Chavez-Chiang CE, Sibbitt WL Jr, Band PA, Chavez-Chiang NR, DeLea SL, Bankhurst AD. The highly accurate anteriolateral portal for injecting the knee. Sports Med Arthrosc Rehabil Ther Technol. 2011 Mar 30;3(1):6. doi: 10.1186/1758-2555-3-6.
Results Reference
derived
PubMed Identifier
21127362
Citation
Ricciardi M, Roldan C, Sibbitt R, Sibbitt W Jr, Michael A, Palmer D. Highly controlled vascular syringes for pericardiocentesis. J Invasive Cardiol. 2010 Dec;22(12):580-4.
Results Reference
derived
PubMed Identifier
21078710
Citation
Sibbitt WL Jr, Band PA, Chavez-Chiang NR, Delea SL, Norton HE, Bankhurst AD. A randomized controlled trial of the cost-effectiveness of ultrasound-guided intraarticular injection of inflammatory arthritis. J Rheumatol. 2011 Feb;38(2):252-63. doi: 10.3899/jrheum.100866. Epub 2010 Nov 15.
Results Reference
derived
PubMed Identifier
21057794
Citation
Sibbitt RR, Palmer DJ, Sibbitt WL Jr, Bankhurst AD. Image-directed fine-needle aspiration biopsy of the thyroid with safety-engineered devices. Cardiovasc Intervent Radiol. 2011 Oct;34(5):1006-13. doi: 10.1007/s00270-010-0013-x. Epub 2010 Nov 6.
Results Reference
derived
PubMed Identifier
19648304
Citation
Sibbitt WL Jr, Peisajovich A, Michael AA, Park KS, Sibbitt RR, Band PA, Bankhurst AD. Does sonographic needle guidance affect the clinical outcome of intraarticular injections? J Rheumatol. 2009 Sep;36(9):1892-902. doi: 10.3899/jrheum.090013. Epub 2009 Jul 31.
Results Reference
derived

Learn more about this trial

Reciprocating Medical Devices - a Study of a New Safety Device

We'll reach out to this number within 24 hrs